Turan Alparslan, Hesler Brian D, You Jing, Saager Leif, Grady Martin, Komatsu Ryu, Kurz Andrea, Sessler Daniel I
From the Departments of Outcomes Research, Quantitative Health Sciences and Outcomes Research, and Anesthesiology Institute, Cleveland Clinic, Cleveland, Ohio.
Anesth Analg. 2014 Sep;119(3):603-612. doi: 10.1213/ANE.0000000000000096.
Vitamin D deficiency is a global health problem. Epidemiological studies demonstrate that vitamin D is both cardioprotective and neuroprotective. Vitamin D also plays a substantial role in innate and acquired immunity. Our goal was to evaluate the association of serum vitamin D concentration on serious postoperative complications and death in noncardiac surgical patients.
We retrospectively analyzed the data of 3509 patients who had noncardiac surgery at the Cleveland Clinic Main Campus and had a serum vitamin D measurement. The relationship between serum vitamin D concentration and all-cause in-hospital mortality, in-hospital cardiovascular morbidity, and serious in-hospital infections was assessed as a common effect odds ratio (OR) by using a multivariate generalized estimating equation model with adjustment for demographic, medical history variables, and type and duration of surgery.
Higher vitamin D concentrations were associated with decreased odds of in-hospital mortality/morbidity (P = 0.003). There was a linear reduction of the corresponding common effect odds ratio (OR 0.93, 95% confidence interval, 0.88-0.97) for severe in-hospital outcomes for each 5 ng/mL increase in vitamin D concentration over the range from 4 to 44 ng/mL. In addition, we found that the odds versus patients with vitamin D <13 ng/mL (i.e., 1st quintile) were significantly lower in patients with vitamin D 13-20, 20-27, 27-36, and > 36 ng/mL (i.e., 2nd-5th quintiles); the corresponding estimated ORs were 0.65 (99% confidence interval, 0.43-0.98), 0.53 (0.35-0.80), 0.44 (0.28-0.70), and 0.49 (0.31-0.78), respectively. However, there was no statistically significant difference among individual quintiles >13 ng/mL.
Vitamin D concentrations were associated with a composite of in-hospital death, serious infections, and serious cardiovascular events in patients recovering from noncardiac surgery. While causality cannot be determined from our retrospective analysis, the association suggests that a large randomized trial of preoperative vitamin D supplementation and postoperative outcomes is warranted.
维生素D缺乏是一个全球性的健康问题。流行病学研究表明,维生素D对心脏和神经均有保护作用。维生素D在先天性和获得性免疫中也发挥着重要作用。我们的目标是评估非心脏手术患者血清维生素D浓度与严重术后并发症及死亡之间的关联。
我们回顾性分析了3509例在克利夫兰诊所主院区接受非心脏手术且进行了血清维生素D检测的患者的数据。通过使用多变量广义估计方程模型,并对人口统计学、病史变量以及手术类型和持续时间进行调整,将血清维生素D浓度与全因住院死亡率、住院心血管发病率和严重院内感染之间的关系评估为共同效应比值比(OR)。
较高的维生素D浓度与降低住院死亡率/发病率的几率相关(P = 0.003)。在4至44 ng/mL范围内,维生素D浓度每增加5 ng/mL,严重院内不良结局的相应共同效应比值比呈线性下降(OR 0.93,95%置信区间,0.88 - 0.97)。此外,我们发现维生素D浓度为13 - 20、20 - 27、27 - 36和> 36 ng/mL(即第2 - 5五分位数)的患者与维生素D浓度<13 ng/mL(即第1五分位数)的患者相比,几率显著降低;相应的估计OR分别为0.65(99%置信区间,0.43 - 0.98)、0.53(0.35 - 0.80)、0.44(0.28 - 0.70)和0.49(0.31 - 0.78)。然而,在>13 ng/mL的各个五分位数之间没有统计学上的显著差异。
维生素D浓度与非心脏手术后恢复患者的住院死亡、严重感染和严重心血管事件的综合情况相关。虽然我们的回顾性分析无法确定因果关系,但这种关联表明有必要进行一项关于术前补充维生素D与术后结局的大型随机试验。